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Introduction
The ability of neurons to remodel and modify their synaptic 
connections is a fundamental requirement for higher brain func-
tions such as learning and memory. Defects in this form of syn-
aptic plasticity have been associated with the pathophysiological 
manifestations of many neurodegenerative diseases and mental 
illnesses (Zoghbi, 2003; Levitt et al., 2004). Increasing evidence 
suggests that signaling cascades initiated by secreted molecules 
such as bone morphogenic protein (BMP), Wnt/wingless (Wg), 
and FGF are essential for the coordinated assembly of the syn-
apse (Packard et al., 2002; McCabe et al., 2003; Waites et al., 
2005; Hodge et al., 2007). Despite recent progress, we know little 
about how these signaling cascades are modulated in neurons to 
ensure appropriate synaptic growth. In this study, we describe   
a mechanism by which BMP signaling is modulated through 
interaction between the Nemo (Nmo) kinase and the BMP 
transcription factor Mad in Drosophila melanogaster larval 
motor neurons.
In vertebrates, BMP signaling has been shown to control 
different aspects of neuronal development both in the spinal 
cord and the brain (Liu and Niswander, 2005). The role for BMP 
signaling in regulating synaptic growth has been well character-
ized at the Drosophila larval neuromuscular junction (NMJ). 
Based on the current evidence, the BMP ligand Glass Bottom 
Boat provides a retrograde signal from the muscle back to the 
nerve terminal; this signal is processed by a receptor complex 
comprised of the type I BMP receptors Thickveins (Tkv) and 
Saxophone and the type II BMP receptor Wishful thinking. 
Receptor activation then leads to an increase in the phosphory-
lation of the R-Smad Mad at the NMJ terminals followed by 
nuclear translocation of phosphorylated Mad (p-Mad) through 
its interaction with the co-Smad Medea. Mutations of the mem-
bers of this cascade lead to a drastic reduction in the number of 
synaptic boutons and the amount of neurotransmitter release at 
the NMJ (Aberle et al., 2002; Marques et al., 2002; McCabe 
et al., 2003, 2004).
B
one morphogenic protein (BMP) signaling is essen-
tial for the coordinated assembly of the synapse, 
but we know little about how BMP signaling is mod-
ulated in neurons. Our findings indicate that the Nemo 
(Nmo) kinase modulates BMP signaling in motor neurons. 
nmo mutants show synaptic structural defects at the Dro-
sophila melanogaster larval neuromuscular junction, and 
providing Nmo in motor neurons rescues these defects. 
We show that Nmo and the BMP transcription factor Mad 
can be coimmunoprecipitated and find a genetic interaction 
between nmo and Mad mutants. Moreover, we demon-
strate that Nmo is required for normal distribution and 
accumulation of phosphorylated Mad in motor neurons. 
Finally, our results indicate that Nmo phosphorylation of 
Mad at its N terminus, distinct from the BMP phosphoryla-
tion site, is required for normal function of Mad. Based on 
our findings, we propose a model in which phosphoryla-
tion of Mad by Nmo ensures normal accumulation and 
distribution of Mad and thereby fine tunes BMP signaling 
in motor neurons.
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than five boutons (Fig. 1, B and C). Different genetically null 
alleles of nmo in trans-allelic and homozygous combinations 
showed a strong reduction in the number of type I synaptic boutons 
(86.5 ± 3.0 and 54.5 ± 3.6 for wild type and nmo
P/Df(3L)Exel6279, 
A large body of research has provided evidence for Smad 
regulation by several posttranslational mechanisms such as ubiq-
uitination, phosphorylation, and sumoylation, to name a few (Ross 
and Hill, 2008); however, we know little about how Smads are 
regulated in neurons. In a forward genetic suppressor screen, 
we have identified Nmo kinase as a regulator of synaptic growth 
at the Drosophila larval NMJ. Our findings provide evidence 
that the normal function of Mad depends on its phosphorylation 
by Nmo. Interaction between Nmo and Mad provides a mecha-
nism for the modulation of BMP signaling in motor neurons 
and thus the structural growth and function of synaptic boutons 
at the NMJ.
Results
Nmo is required in motor neurons for 
normal synaptic growth at the larval NMJ
Loss-of-function mutations in the E3 ubiquitin ligase highwire 
(hiw) lead to extensive synaptic expansion at the NMJ (Wan 
et al., 2000). We reasoned that if a candidate gene could domi-
nantly suppress the synaptic expansion in hiw mutants, it would 
likely be involved in the regulation of synaptic growth. To search 
for such candidate genes, we tested whether inclusion of a chro-
mosome containing deletions (deficiency chromosome) could 
dominantly suppress the synaptic expansion in hiw mutants. 
We focused on chromosomal deficiency lines available on the 
left arm of the third chromosome and found that hiw larvae with 
one copy of Df(3L)pbl-X1 showed significantly less synaptic 
expansion compared with hiw larvae. We tested genetic interaction 
with smaller overlapping deficiencies and were able to identify 
the gene nmo (Choi and Benzer, 1994) as the locus responsible 
(see Materials and methods; Fig. S1).
Nmo is the founding member of the evolutionarily con-
served Nmo-like kinase family of serine/threonine kinases (Choi 
and Benzer, 1994). Nmo was first identified as a regulator of 
epithelial planar cell polarity during eye development (Choi and 
Benzer, 1994). Moreover, Nmo has been implicated in several 
developmental processes, including the regulation of patterning 
and imaginal disc development (Zheng et al., 1995; Verheyen 
et al., 2001), but its function in the nervous system has not been 
characterized. To study the role of Nmo in synaptic growth, we 
examined NMJs from wandering third instar larvae using anti-
bodies against pre- and postsynaptic markers. NMJs undergo 
rapid structural and functional growth in the few days of larval 
development; during this time, the number of synaptic boutons 
increases several fold to keep up with the growing muscle 
(Schuster et al., 1996; Keshishian, 2002; Davis, 2006). This co-
ordinated growth appeared defective in nmo mutants (Fig. 1); 
however, we did not observe any detectable abnormalities in the 
pattern of innervation of the body wall muscles in nmo mutant 
larvae (not depicted), suggesting that motor neuronal pathfind-
ing and initial target recognition are not affected. A feature of 
wild-type NMJs is the presence of chains of synaptic boutons 
organized like beads on a string (Budnik et al., 1996; Zito et al., 
1999) forming synaptic branches that contain as many as 20 bou-
tons (Fig. 1 A). However, in nmo mutants, this feature was   
severely affected, as most NMJs lacked branches containing more 
Figure 1.  Nmo is required for normal synaptic growth at the NMJ. (A) Wild- 
type (wt) third instar larval NMJ synapses at muscles 6 and 7 in the 
third abdominal segment double stained with anti-Dlg (red) and anti-HRP 
(green). The arrow indicates a type Is bouton; the arrowhead indicates a 
type Ib bouton. (B and C) NMJs at muscles 6 and 7 in two different nmo 
mutant combinations. (D) Bar graph showing the normalized total number 
of boutons/MSA in wild type and in three nmo mutant combinations (n ≥ 20; 
mean ± SEM; ***, P < 0.001). Bar, 10 µm.715 NEMO MODULATES SYNAPTIC GROWTH • Merino et al.
motor neurons, the ability of Nmo protein to localize to pre-
synaptic structures, and the rescue of synaptic defects in nmo 
mutants by presynaptic Nmo together led us to conclude that Nmo 
is required in presynaptic motor neurons for normal growth of 
NMJ synaptic structures.
Nmo binds Mad and is required for normal 
accumulation of p-Mad in motor neurons
Our findings indicated that genetic reduction of nmo in motor 
neurons can significantly suppress NMJ overexpansion in hiw 
mutants (Fig. S1, A–D). Previously, it has been shown that loss 
of Wallenda (Wnd), a MAPK kinase kinase, can lead to sup-
pression of the hiw loss-of-function phenotype (Collins et al., 
2006). Wnd levels are up-regulated in the central nervous sys-
tem of hiw mutant larvae (Collins et al., 2006). Therefore, we 
tested whether Wnd protein levels in the central nervous system 
are affected as a consequence of loss of nmo. We found no 
detectable changes in the levels of anti-Wnd antibody signal as-
sociated with loss of nmo (Fig. S1, E–I). Synaptic overexpan-
sion in hiw mutants is also dependent on normal BMP signaling 
in motor neurons (McCabe et al., 2004). Moreover, it has re-
cently been demonstrated that Nmo can interact with and phos-
phorylate the BMP transcription factor Mad in vitro (Zeng   
et al., 2007). Therefore, we examined whether Nmo participates 
in the regulation of BMP signaling in motor neurons. As a first 
step, we set out to test whether the normal accumulation of 
p-Mad is affected in nmo mutants. p-Mad accumulation at the 
terminals and in the nuclei of motor neurons is an indicator of 
retrograde BMP signaling at the NMJ (Marques et al., 2002; 
McCabe et al., 2003). Using an anti–p-Mad antibody, we were 
able to detect p-Mad in the nuclei of motor neurons in wild-type 
and nmo mutants (Fig. 3, A–F); however, our quantification of 
the fluorescence intensity associated with the p-Mad signal in 
the ventral nerve cord showed an 30% (P < 0.001) decrease   
in nmo mutants compared with wild type (Fig. 3, A–F and J).   
In contrast, we found a strong increase in the p-Mad signal at the 
NMJs. We quantified this increase in two ways. First, we mea-
sured the intensity of the signal per individual p-Mad punctum 
between the two groups and found that nmo mutants show a 
25% increase compared with wild type (P < 0.001; Fig. 3 K–P 
and T). Second, we measured the total amount of fluorescence 
per synaptic area for p-Mad and normalized it to the amount of 
fluorescence for Fas2 in the same synaptic area between the two 
groups; using this measurement, we found that p-Mad signal 
was increased by 35% in nmo mutants compared with wild type 
(n = 16; P < 0.001). The p-Mad signal in nmo mutants was re-
stored to normal levels when we provided Nmo in motor neu-
rons (Fig. 3, G–J and Q–T). To rule out the possibility that the 
abnormal accumulation of p-Mad is merely caused by a general 
defect in axonal transport in nmo mutants, we examined motor 
axons in nmo and wild-type larvae after overexpression of UAS-
Mito-GFP (Cox and Spradling, 2003). UAS-Mito-GFP is a marker 
for mitochondria and can be used in live larvae to assess retro-
grade and anterograde axonal transport (Pilling et al., 2006). We 
did not find any abnormalities or apparent differences in the 
accumulation of Mito-GFP puncta in nmo mutant larvae (Fig. S2, 
A–E). Similarly, we did not observe any apparent differences   
respectively; n = 20; P < 0.001) at muscles 6 and 7. Type I gluta-
matergic boutons have been divided into two categories, big 
(type Ib) and small (type Is), based on their size as well as on 
the intensity of their Discs large (Dlg) signal (Fig. 1 A, arrow-
head and arrow; Budnik et al., 1996). We found that both Ib and 
Is boutons were reduced in nmo mutants. We observed a similar 
reduction in the number of boutons at muscle 4 NMJs (58.9 ± 2.6 
and 35.3 ± 3.3 for wild type and nmo
P/Df(3L)Exel6279, respec-
tively; n = 20; P < 0.001). To accurately reflect the role of Nmo 
in coordinated synaptic growth, we normalized the total number 
of boutons at every NMJ to the corresponding muscle surface 
area (MSA). This approach avoids any biases that might arise as 
the result of variations in the muscle size among different larvae. 
Our quantifications showed that in nmo mutants, the number of 
boutons per MSA was reduced by 40% (Fig. 1 D).
In situ hybridization experiments have previously demon-
strated an enrichment of nmo transcript in the ventral nerve cord 
and in the brain at late embryonic stages (Verheyen et al., 2001). 
To further test whether the nmo transcript is present in motor 
neurons, we took advantage of a nmo LacZ enhancer trap fly 
(nmo
P); expression of -galactosidase (-gal) from nmo
P closely 
resembles the endogenous expression pattern of nmo (Choi and 
Benzer, 1994; Zheng et al., 1995; Zeng and Verheyen, 2004). 
We were able to detect a specific anti–-gal signal in a subset of 
neurons, including all motor neurons, in the ventral nerve cord. 
To confirm the identity of the -gal–positive neurons in nmo
P, 
we costained the ventral nerve cord with an antibody against 
p-Mad; p-Mad normally accumulates in the nuclei of motor 
neurons (Marques et al., 2002; McCabe et al., 2003). We found 
that all p-Mad–positive motor neurons were also positive for 
-gal (Fig. 2, A–F). To further assess the expression pattern of 
the nmo transcript, we generated larvae that contained one copy 
of nmo
P enhancer trap while expressing upstream activating se-
quence (UAS)–mCD8-GFP in all motor neurons using motor 
neuronal Gal4 driver BG380; double staining of ventral nerve 
cords with anti-GFP and anti–-gal antibodies revealed that the 
nmo transcript is not exclusively expressed in motor neurons 
(unpublished data). Next, we wished to examine the pattern of 
expression of Nmo protein; however, the available Nmo anti-
bodies failed to detect a specific signal. Thus, we turned to a GFP-
Nmo  fusion  transgene  (UAS-GFP-Nmo;  Fiehler  and  Wolff, 
2008) to investigate whether Nmo can localize at synaptic sites. 
We detected GFP signal at all NMJ synapses after overexpres-
sion of UAS-GFP-Nmo using BG380-Gal4 (Fig. 2, G and H), 
suggesting that Nmo protein can localize to the NMJ. In addi-
tion, we found that GFP-Nmo was evenly distributed in motor 
neuronal cell bodies and nuclei without any apparent concentra-
tion in any compartments (Fig. 2 I). We did not find a significant 
change in the number of boutons per MSA in response to Nmo 
overexpression (Fig. 2 J).
To determine whether Nmo is required pre- or postsynap-
tically, we performed genetic rescue experiments in nmo mutant 
larvae. We found that motor neuronal overexpression of UAS-
Nmo or UAS-GFP-Nmo but not muscle overexpression was able 
to rescue the reduction in the number of boutons per MSA in 
nmo mutants (NMJs at muscles 6 and 7, Fig. 2, N–R; NMJs at 
muscle 4, Fig. 2 K–M). The presence of nmo transcription in JCB • VOLUME 185 • NUMBER 4 • 2009   716
Nmo and Mad have been shown to interact in vitro (Zeng 
et al., 2007); therefore, we wished to verify whether Nmo and 
Mad also interact in larval tissue. In the absence of reliable 
anti-Mad and anti-Nmo antibodies, we decided to use tagged 
in the accumulation of synaptotagmin (Syt; Fig. S2, F–N),   
Bruchpilot, or Fas2 in axons of nmo mutant larvae (not depicted). 
These results suggest that Nmo specifically influences p-Mad 
distribution and accumulation in motor neurons.
Figure 2.  Nmo is required in motor neurons for normal synaptic growth at the NMJ. (A) -gal staining in the ventral nerve cord of larvae heterozygous 
for nmo
P. (B) -gal–positive neurons are also p-Mad positive. (C) Merged image of A and B; p-Mad is shown in green, and -gal is shown in red. 
(D–F) Graphic representation of signal intensity in individual motor neurons corresponding to A–C. (G) The transgenic GFP-Nmo fusion protein localizes to 
the presynaptic domain of the NMJ when expressed in motor neurons. (H) The same NMJ is stained with an anti-HRP antibody, and the merged image is 
shown. (I) Overexpressed GFP-Nmo also localizes to motor neuronal cell bodies. (J) Bar graph showing the normalized total number of type I boutons 
per MSA in wild type (wt) and larvae overexpressing GFP-Nmo in motor neurons (n ≥ 20; mean ± SEM). (K–M) Larval NMJ synapses at muscle 4 double 
stained with anti-Dlg (red) and anti-HRP (green) antibodies in wild type (K), nmo mutant (L), and nmo mutant overexpressing GFP-Nmo in motor neurons (M). 
(N–Q) Larval NMJ synapses at muscles 6 and 7 in wild type (N), nmo mutant (O), nmo mutant overexpressing Nmo in motor neurons (P), or nmo mutant 
overexpressing Nmo in muscles (Q). (R) Bar graph showing the normalized total number of type I boutons per MSA in the genotypes shown in N–Q (n = 20; 
mean ± SEM; ***, P < 0.001). Bars, 10 µm.717 NEMO MODULATES SYNAPTIC GROWTH • Merino et al.
transgenes of Mad and Nmo. For this, we generated an Myc-
tagged Mad transgene and coexpressed it together with GFP-Nmo 
in all motor neurons. We found a significant overlap between the 
signals associated with Myc-Mad and GFP-Nmo at the NMJ 
(Fig. 3, U–W). In addition, we used Myc-Mad together with 
GFP-Nmo in coimmunoprecipitation experiments. We found that, 
in preparations which were immunoprecipitated with the anti-
Myc antibody, we could also detect the presence of Nmo using 
an anti-GFP antibody (Fig. 3 X), suggesting that Mad and Nmo 
can be present in the same protein complex.
Phosphorylation of Mad by Nmo is required 
for the normal function of Mad
Next, we investigated whether phosphorylation of Mad by Nmo is 
required for Mad’s normal physiological function in motor 
neurons. Nmo can specifically phosphorylate Mad in vitro at serine 
25, a site distinct from the phosphorylation site by type I BMP re-
ceptors at the C terminus of Mad (ten Dijke and Hill, 2004; Zeng 
et al., 2007). If Nmo indeed phosphorylates Mad in vivo, and if 
this phosphorylation is physiologically relevant, its loss should 
affect the ability of Mad to function normally in the nervous system. 
We tested this hypothesis by performing rescue experiments in 
Mad mutants using a Mad transgene that cannot be phosphory-
lated by Nmo (UAS-Myc-Mad
S25A). Neuronal overexpression of 
UAS-Myc-Mad was able to restore the number of boutons per 
MSA in Mad mutants; however, UAS-Myc-Mad
S25A rescued Mad 
mutants only partially (Fig. 4, A–E). We verified that Myc-Mad 
and Myc-Mad
S25A showed similar levels of expression in motor 
neurons by Western blotting (Fig. S3). Protein levels were quanti-
fied by densitometry, and comparable protein levels were found.
Figure 3.  Nmo is required for the normal accumulation of p-Mad in motor neurons, and it colocalizes and coimmunoprecipitates with Mad. (A–I) Motor 
neuron nuclei in third instar larval ventral nerve cords double stained with DAPI (red) and p-Mad (green) in wild-type (wt; A–C), nmo mutant (D–F), and 
nmo mutant larva overexpressing UAS-Nmo in motor neurons (G–I). (K–S) Terminal boutons at muscle 4 NMJs double stained with anti-Fas2 (red) and 
anti–p-Mad (green) antibodies in wild-type (K–M), nmo mutant (N–P), and nmo mutant larva overexpressing the Nmo transgene in motor neurons (Q–S).   
(J and T) Box plots showing the total fluorescence corresponding to the p-Mad signal in motor neuron nuclei (J) or the mean intensity of p-Mad puncta   
at the NMJ (T) for the aforementioned genotypes. n ≥ 80 motor neurons in J, and n ≥ 175 synaptic boutons in T from at least 10 larvae (mean ± SEM;   
***, P < 0.001). (U–W) Synaptic boutons stained with anti-GFP (green; U) and anti-Myc (red; V) and the merged image (W) are shown. Insets show   
partial 3D reconstructions of a synaptic bouton. (X) Western blots showing the presence of GFP-Nmo after immunoprecipitation (IP) of Myc-Mad using   
an anti-Myc antibody. VNC, ventral nerve cord. Bars, 10 µm.JCB • VOLUME 185 • NUMBER 4 • 2009   718
prompted us to test whether nmo and Mad could genetically   
interact. To test this possibility, we asked whether Mad and nmo 
would show trans-heterozygous genetic interaction. We found 
that synaptic structures showed significant abnormalities when 
one copy of nmo and one copy of Mad were genetically removed 
(Fig. 5, A–E), whereas loss of one copy of either was not signifi-
cantly different from wild type. The number of type I boutons 
per MSA in Mad
+/;nmo
+/ trans-heterozygous larvae was   
reduced by >30% compared with heterozygous control larvae 
(Fig. 5 E). This trans-heterozygous interaction was rescued by 
neuronal overexpression of Nmo in different trans-allelic com-
binations (Fig. 5 E). To further examine the functional inter-
action between Mad and Nmo, we tested synaptic structures in 
Mad;nmo double mutants. We found that the number of boutons 
per MSA in these larvae was statistically similar to that in Mad 
mutants alone but significantly lower from that in nmo mutants 
(Fig. 5, F–J). These results suggest that Mad and Nmo most likely 
function together in the same pathway to control synaptic growth 
at the NMJ. These results also raise the possibility that an in-
crease in BMP signaling may be capable of restoring synaptic 
defects in nmo mutants. We tested this hypothesis by overex-
pressing either UAS-Myc-Mad or a constitutively active form 
of the type I BMP receptor Tkv (UAS-Tkv-act; Hoodless et al., 
1996) in motor neurons in nmo mutant larvae. UAS-Tkv-act has 
been shown to increase the amount of p-Mad in the nuclei of 
motor neurons (Collins et al., 2006) without affecting the num-
ber of boutons at the NMJ (McCabe et al., 2004). Overexpres-
sion of either UAS-Myc-Mad or UAS-Tkv-act did not affect the 
number of boutons per MSA (Fig. 5 K). Although overexpres-
sion of Mad did not significantly increase the number of bou-
tons in nmo mutant larvae, overexpression of UAS-Tkv-act did 
so significantly (60.77 ± 2.6 for BG380;nmo
/ compared with 
75.67 ± 6.6 for BG380;UAS-Tkv-act/+;nmo
/; n = 12; P = 0.018; 
Fig. 5 K and Fig. S5, A–D). These results further support a 
model in which Nmo regulates synaptic structural growth at the 
NMJ via its interaction with BMP signaling in motor neurons.
Nmo overexpression negatively regulates 
synaptic release
Loss of BMP signaling has a profound effect on neurotrans-
mitter release at the NMJ (Aberle et al., 2002; McCabe et al., 2004). 
Based on our results, we predicted that loss of nmo would mimic 
partial loss of BMP signaling, leading to a decrease in quantal 
release. Using a standard two-electrode voltage-clamp technique, 
we evaluated electrophysiological properties of nmo mutant lar-
vae by measuring postsynaptic evoked junctional currents (EJCs) 
as well as miniature EJCs (mEJCs). To our surprise, quantal 
content in nmo mutants appeared normal. Although EJCs, quan-
tal content, and mEJC frequency showed an increase on average 
compared with wild type, we did not find any statistically signifi-
cant difference between the two groups (quantal content, 25.92 ± 
4.7 for control vs. 29.23 ± 3.25 for nmo; n = 12; P = 0.56;   
EJC, P = 0.25; frequency of mEJC, P = 0.16; Fig. 6, A, C, and G). 
In contrast, Mad mutants, as reported previously (McCabe   
et al., 2004), showed a severe reduction in quantal release com-
pared with wild type (Fig. 6, B and G). These results suggested 
that the normal function of Mad in the regulation of synaptic 
We next analyzed the localization of these two transgenes 
using immunohistochemistry in larval preparations. We found 
that both Myc-Mad and Myc-Mad
S25A were detectable in motor 
neuronal nuclei and at synaptic terminals (Fig. 4, F–K). How-
ever, closer analysis of the Myc signal revealed a propor-
tional increase at the NMJ versus motor neuronal nuclei for 
Myc-Mad
S25A compared with Myc-Mad. For this, we generated 
an index representing the Myc signal at the NMJ in relation to the 
Myc signal in the nuclei of motor neurons for each larva. Using 
confocal projections, we measured the amount of fluorescence 
signal at the NMJ per area and divided that by the amount of fluor-
escence per area obtained from motor neuronal nuclei for each 
larva (see Materials and methods). On average, larvae expressing 
Myc-Mad
S25A showed a >50% increase in this index compared 
with larvae that expressed Myc-Mad (P < 0.05; n = 12; Fig. 4 L), 
which is reminiscent of the distribution of p-Mad in nmo mutants 
(Fig. 3). Then, we tested the effect of loss of nmo on this distribu-
tion index and found that loss of nmo led to an 45% increase in 
the index with a p-value of 0.0504 (n = 12; Fig. 4 L).
Because Nmo has been shown to induce nuclear export of 
Mad in heterologous cells, we wished to examine the role of 
Nmo in inducing nuclear export of Mad in motor neurons. For 
this, we quantified the amount of fluorescence in the nuclei of 
motor neurons expressing Myc-Mad and divided that by the 
amount of fluorescence obtained from the entire cell body in 
each motor neuron in the presence or absence of nmo; we found 
no significant difference between the nuclear fraction of Myc 
signal between wild-type and nmo larvae (Fig. 4 M). Similarly, 
the  nuclear  fraction  of  Myc  signal  in  larvae  overexpressing 
UAS-Myc-Mad
S25A was not different from that of wild-type 
UAS-Myc-Mad (Fig. 4 M). These findings are consistent with 
our earlier observations of p-Mad distribution in nmo mutant 
larvae and suggest that phosphorylation of Mad at serine 25 by 
Nmo is not essential for normal nuclear export of Mad in motor 
neurons. Nevertheless, these results do not rule out the possibil-
ity that Nmo can induce nuclear export of Mad when over-
expressed, as observed previously by Zeng et al. (2007).
Finally, we tested the importance of Nmo’s kinase activity 
in the regulation of p-Mad accumulation and distribution in 
motor neurons. We generated a transgenic Nmo carrying a point 
mutation in a critical residue in the catalytic domain of Nmo, 
UAS-GFP-Nmo
K69M. When overexpressed in motor neurons, 
GFP-Nmo
K69M localized to NMJ terminals in a manner similar 
to GFP-Nmo but caused a mild reduction in the number of bou-
tons (Fig. S4, A–E), suggesting that it perhaps acts as a dominant 
negative. We tested whether Nmo
K69M can rescue the abnormal 
p-Mad distribution in motor neurons in nmo mutants, and, not 
surprisingly, we found that it failed to restore p-Mad to normal 
levels (Fig. 4, N–W; and Fig. S4, F–I). These findings are con-
sistent with a model in which Nmo phosphorylation of Mad at 
serine 25 influences the distribution and accumulation of Mad 
in motor neurons and is required for Mad’s normal function in 
promoting synaptic growth.
nmo and Mad genetically interact
The effect of nmo loss-of-function on p-Mad distribution as 
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Figure 4.  Nmo phosphorylation of Mad is required for its normal function and distribution in motor neurons. (A–D) Larval NMJs at muscle 4 double 
stained with anti-Dlg (red) and anti-HRP (green) in wild type (wt; A), homozygous Mad
237 (B), and Mad
237 rescued by UAS-Myc-Mad
S25A (C) or UAS-Myc-
Mad (D). (E) Bar graph showing the normalized total number of boutons per MSA in the genotypes shown in A–D (n ≥ 14; mean ± SEM; **, P < 0.01; 
***, P < 0.001). (F–K) Ventral nerve cords (F–H) and NMJs (I–K) stained with anti-Myc in wild-type larvae overexpressing UAS-Myc-Mad (F and I) or 
UAS-Myc-Mad
S25A (G and J) and nmo mutant larvae overexpressing UAS-Myc-Mad (H and K). (L) Bar graph showing the normalized index of mean fluor-
escence intensity for the Myc signal at the NMJ versus motor neuron nuclei for Myc-Mad, Myc-Mad
S25A, and Myc-Mad in nmo mutants (n = 16 larvae and 
two NMJs per larva; mean ± SEM; *, P < 0.05). (M) Bar graph showing the nuclear versus cytoplasmic Myc signal from wild-type larvae overexpressing 
Myc-Mad or Myc-Mad
S25A and from nmo mutants overexpressing Myc-Mad using BG380-Gal4 (n ≥ 40 from five larvae; mean ± SEM). (N–U) Terminal 
boutons at muscle 4 NMJs double stained with anti–p-Mad (green) and anti-HRP (red) in wild type (N and O), nmo mutant (nmo
DB24/Df(3L)Exel6279; 
P and Q), nmo mutant larva overexpressing GFP-Nmo transgene in motor neurons (R and S), and nmo mutant larva overexpressing GFP-Nmo
K69M in motor 
neurons (T and U). (V) Bar graph showing p-Mad fluorescence relative to HRP for the genotypes in N–U (n = 8 larvae; mean ± SEM; *, P < 0.05; **, P < 0.01). 
(W) Bar graph showing p-Mad fluorescence intensity in the nuclei of dorsal motor neurons for the genotypes in N–U (n > 200 motor neurons from 8–10 
larvae; mean ± SEM; *, P < 0.05; **, P < 0.01). Bars, 10 µm.JCB • VOLUME 185 • NUMBER 4 • 2009   720
Figure 5.  nmo and Mad genetically interact. (A–D) NMJs at muscle 4 double stained with anti-Dlg (red) and anti-HRP (green) in wild type (wt; A), hetero-
zygous nmo mutants (B), heterozygous Mad mutants (C), and trans-heterozygous Mad
/+;nmo
/+ mutants (D). (E) Bar graph showing the normalized 721 NEMO MODULATES SYNAPTIC GROWTH • Merino et al.
findings, it is tempting to conclude that the reduction in the 
number of NMJ synaptic boutons in nmo mutants is, to a large 
extent, caused by the failure of p-Mad to signal to the nucleus ef-
fectively. In support of this, we reveal a strong trans-heterozygous 
interaction between nmo and Mad and show that synaptic de-
fects in nmo mutants can be partially rescued by overexpression 
of a constitutively active form of Tkv (Tkv-act). Although our 
current findings provide strong support for this model, we can-
not rule out the possibility that Nmo is involved in other pro-
cesses that contribute to the growth of synaptic boutons at 
the NMJ.
We find that, in contrast to its critical role in the regulation 
of synaptic structure, Nmo does not play an important role in 
the regulation of synaptic function; in the absence of nmo, quan-
tal content remains at normal levels. Consistently, we find that 
the Mad
S25A transgene is capable of rescuing the severe electro-
physiological defects of Mad mutants as efficiently as a wild-
type Mad transgene. Previously, it has been suggested that 
structural growth and the homeostasis of neurotransmitter release 
at the NMJ have different requirements for BMP signaling 
(Goold and Davis, 2007). Similarly, our findings highlight the 
differential requirements for the regulation of synaptic structure 
and synaptic strength via BMP signaling. Interestingly, although 
overexpression of Nmo in motor neurons does not influence 
synaptic structural growth, it does cause a significant reduction 
in neurotransmitter release. This observation is consistent with 
those made by Zeng et al. (2007), showing an antagonistic 
effect of Nmo gain-of-function on Mad in the wing imaginal 
discs. Nevertheless, although this observation shows a potential 
for Nmo to act as a negative regulator of Mad, our findings 
argue against a significant negative regulatory role for Nmo in 
motor neurons under normal physiological conditions.
We propose that Nmo exerts its action primarily by modu-
lating Mad’s retrograde movement from the NMJ to the nucleus. 
Nmo has been implicated in the regulation of Mad nuclear export 
in heterologous cells (Zeng et al., 2007); however, we find no evi-
dence for changes in Mad nuclear export as a consequence of loss 
of nmo. In contrast, we find that Nmo is required for accumula-
tion of p-Mad in the nuclei of motor neurons. In the absence of 
nmo, p-Mad levels increase at the NMJ and decrease in the nuclei 
of motor neurons, suggesting that Nmo is required for normal 
translocation/trafficking of Mad from the NMJ to the nucleus.
Finally, we show that, consistent with previous findings 
(Zeng et al., 2007), overexpression of Nmo can reduce the pro-
portion of Mad concentration in nuclei versus that in cell bodies 
of motor neurons. Based on the phenotypic consequences of 
nmo loss- and gain-of-function, it appears that normal growth of 
synaptic structures at the NMJ depends on continuous and effi-
cient BMP signaling from the NMJ to the nuclei of motor   
neurons and is less sensitive to the residence time of Mad in   
strength is not dependent on Nmo. In support of this conclusion, 
both UAS-Myc-Mad and UAS-Myc-Mad
S25A were capable of 
restoring  normal  synaptic  function  in  Mad  mutant  larvae 
(Fig. 6, D, E, and G). These results suggest that the regulation 
of synaptic structural growth and tuning of synaptic strength have 
differential requirements for Mad signaling in motor neurons.
To further explore the action of Nmo on the regulation of 
neurotransmitter release, we conducted quantal analysis of lar-
vae overexpressing Nmo (Fig. 6, F and G). Our analysis of syn-
aptic structures showed no significant change in the number of 
synaptic boutons in response to Nmo overexpression (Fig. 2 J); 
however, unexpectedly, we found a drastic reduction in both 
EJCs and quantal content in response to Nmo overexpression in 
motor neurons (quantal content, 25.92 ± 4.7 for control vs. 
14.38 ± 1.49 for UAS-GFP-Nmo; n = 12; P = 0.012; EJC, P = 
0.007; Fig. 6, F and G). To learn about the relationship between 
this negative regulation and Nmo’s interaction with Mad, we 
evaluated the distribution of Myc-Mad in motor neurons in re-
sponse to Nmo gain-of-function. We found that in these larvae, 
Myc-Mad was present in both motor neuronal cell bodies and 
nuclei as well as at the NMJ (Fig. 6, H–J); however, the nuclear 
distribution of Myc-Mad appeared severely affected. Although 
Myc-Mad normally shows a strong concentration in the nuclei 
of motor neurons, when overexpressed together with GFP-Nmo, 
the Myc signal appeared evenly distributed in the cell body to a 
point that most nuclei were not easily detectable (Fig. 6 I). 
These results reveal a potential role for Nmo in the negative 
regulation of Mad, a role which was not revealed through our 
analysis of nmo loss-of-function, and highlight the ability of 
Nmo to regulate synaptic structural growth and neurotrans-
mitter release differentially.
Discussion
Our findings point to a model in which Nmo phosphorylation of 
Mad promotes its accumulation in the nuclei of motor neurons 
and thereby ensures effective BMP signaling at the NMJ. nmo 
mutant larvae show a significant aberration in the accumulation 
and/or distribution of p-Mad in motor neurons, with elevated 
levels of p-Mad at the NMJ and decreased levels of p-Mad in 
the nuclei of motor neurons. In addition, when Mad is mutated 
at its phosphorylation site for Nmo (Mad
S25A), it shows an ex-
pression pattern that qualitatively resembles that of p-Mad in 
nmo mutants, with more accumulation at the NMJ and less ac-
cumulation in the nucleus compared with wild-type Mad. Con-
sistent with the importance of this phosphorylation, Mad
S25A 
fails to rescue synaptic structural defects in Mad mutants effec-
tively. These observations suggest that phosphorylation of Mad 
by Nmo most likely modulates Mad’s function by regulating its 
distribution and accumulation in motor neurons. Based on our 
total number of boutons/MSA in wild type, heterozygous nmo and Mad mutants, trans-heterozygous Mad;nmo mutants, and trans-heterozygous Mad;nmo 
mutants overexpressing Nmo in motor neurons (n ≥ 12; mean ± SEM; ***, P < 0.001). (F–I) NMJs at muscle 4 double stained with anti-Dlg (red) and 
anti-HRP (green) in wild type (F), homozygous nmo mutants (G), homozygous Mad mutants (H), and Mad;nmo double mutants (I). (J) Bar graph showing 
the normalized total number of boutons/MSA for the genotypes in F–I (n ≥ 20; mean ± SEM; ***, P < 0.001). (K) Bar graph showing the normalized total 
number of boutons/MSA in wild-type and nmo mutant larvae as well as in wild-type or nmo mutant larvae overexpressing UAS-Myc-Mad or UAS-Tkv-act 
using BG380-Gal4 (n ≥ 10; mean ± SEM; *, P < 0.05; ***, P < 0.001). Df corresponds to Df(3L)Exel6279. Bars, 10 µm.
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Figure 6.  Loss of nmo does not lead to electrophysiological defects at the NMJ. (A–F) Representative traces of EJCs and mEJCs from control (A), Mad 
mutant (B), or nmo mutant larvae (C) or from Mad mutant larvae presynaptically expressing UAS-Myc-Mad (D) or UAS-Myc-Mad
S25A (E) and from larvae 
overexpressing UAS-GFP-Nmo (F). In each panel, the top traces show 10 superimposed EJCs, and the bottom traces show the continuous recording   
of spontaneous mEJCs without nerve stimulation. The horizontal scale indicates time (40 ms for EJCs and 400 ms for mEJCs), and the vertical scale   723 NEMO MODULATES SYNAPTIC GROWTH • Merino et al.
5-GGACGACGAGTGGCCTTGATGAAGCTGCCAAATGTGTTCC-3  and 
5-GGAACACATTTGGCAGCTTCATCAAGGCCACTCGTCGTCC-3. Trans-
genic Mad lines were generated according to standard protocols (Spradling 
and Rubin, 1982), whereas the GFP-Nmo
K69M construct was injected by 
Best Gene, Inc.
Western blots and coimmunoprecipitation
Dissected third instar larvae were used for Western blotting as well as for 
immunoprecipitation experiments. Protein extraction was performed ac-
cording to standard protocols. The following antibodies were used: mouse 
anti-GFP (1:500; Clontech Laboratories, Inc.), mouse anti–-actin (1:2,000; 
Millipore), and mouse anti-Myc (1:200; Developmental Studies Hybrid-
oma Bank). Peroxidase-conjugated secondary antibodies (1:5,000; Invit-
rogen) and ECL reagents (GE Healthcare) were used to detect the antigens. 
Densitometric analysis was performed using MetaMorph software (MDS 
Analytical  Technologies).  For  immunoprecipitation  experiments,  protein 
from larvae overexpressing Myc-Mad was immunoprecipitated using an 
Anti–c-Myc Immunoprecipitation kit (Sigma-Aldrich). Immunoprecipitation 
was followed by Western blot analysis.
Immunochemistry
Wandering third instar larvae were dissected in cold HL3 (Stewart et al., 
1994), fixed in 4% PFA (Sigma-Aldrich), incubated overnight with primary 
antibodies at 4°C, and incubated with fluorescence-conjugated secondary 
antibodies at room temperature. The following antibodies were used: rab-
bit polyclonal against GFP (1:500; A6455; Invitrogen), rabbit polyclonal 
against PS1 (1:500) and PS3 (1:200; p-Mad; provided by P. ten Dijke 
[Leiden University, Leiden, Netherlands] and C.H. Heldin [Ludwig Institute 
for Cancer Research, Stockholm, Sweden]; Tanimoto et al., 2000; Sun et al., 
2007), mouse monoclonal against Dlg (1:500; provided by C. Goodman, 
University of California, San Francisco, San Francisco, CA; Parnas et al., 
2001), rabbit anti-Syt (1:2,000; provided by H. Bellen, Baylor College   
of Medicine, Houston, TX; Littleton et al., 1993), rabbit anti-Wnd (1:300; 
provided by A. DiAntonio [Washington University, St. Louis, MO] and 
C. Collins [University of Michigan, Ann Arbor, MI]; Collins et al., 2006), 
mouse monoclonal against Fas2 (1:20; Schuster et al., 1996), and Cy5-
conjugated goat against HRP (1:250; Jackson ImmunoResearch Laborato-
ries).  Antibodies  obtained  from  the  Developmental  Studies  Hybridoma 
Bank  were  mouse  monoclonal  against  Myc  (1:20;  9E10)  and  mouse 
monoclonal  against  -gal  (1:500;  40-1A).  Secondary  antibodies  used 
were Alexa Fluor 488–conjugated goat against rabbit (1:500; Invitrogen) 
and Cy3-conjugated goat against mouse (1:500; GE Healthcare). DAPI 
was used at 1× (Sigma-Aldrich) together with the secondary antibodies. 
Samples were mounted in Vectashield (Vector Laboratories).
Confocal imaging and bouton counts
Synapses and ventral nerve cords were imaged using a ConfoCor LSM 
510 META on an inverted microscope (Axiovert 200M; Carl Zeiss, Inc.). 
Settings were optimized for detection without saturating the signal. Images 
were obtained at room temperature using a Plan-Apochromat 63× NA 1.4 
immersion oil objective lens (Carl Zeiss, Inc.) and Immersol oil 518N (Carl 
Zeiss, Inc.). Images were cropped using Photoshop CS2 (Adobe).
Synaptic boutons were counted as previously described (Schuster 
et al., 1996) using the muscles of segment 3, with the following modifica-
tions: NMJs were costained with anti-Dlg and anti-HRP antibodies, and the 
counts were performed with a 63× NA 1.4 oil immersion objective using 
an epifluorescence microscope (Imager Z1; Carl Zeiss, Inc.).
Fluorescence quantification
Maximum projection images of NMJs and ventral nerve cords were gener-
ated from stacked confocal images (0.32 and 0.5 µm thickness, respec-
tively). To compare intensities of p-Mad puncta at NMJs, synaptic boutons 
were manually traced using Fas2 staining. p-Mad immunofluorescence lev-
els were quantified by measuring the intensity using the LSM5 META MK4 
software (Carl Zeiss, Inc.). The peak signal intensities of p-Mad puncta, 
the nucleus. However, it appears that regulation of neurotrans-
mitter release is more sensitive to the residence time of Mad in the 
nucleus and less dependent on the continuous retrograde signaling 
from the NMJ. Our findings highlight the importance of Nmo 
phosphorylation of Mad at serine 25 in this process; however, a 
comprehensive understanding of the regulation of Mad traffick-
ing and movement dynamics in different cellular compartments 
will require future studies.
Finally, an intriguing possibility would be the involve-
ment of the Wg pathway in the regulation of Mad dynamics 
through Nmo. Nmo has been implicated in the Wg pathway dur-
ing wing development and has been shown to be a transcrip-
tional target of Wg (Zeng and Verheyen, 2004). As Wg has been 
shown to participate in the regulation of synaptic growth at the 
NMJ (Packard et al., 2002), it would be tempting to envisage a 
role for Wg in the regulation of Nmo transcription in motor neu-
rons and thus a link between the Wg and BMP pathways in the 
regulation of synaptic growth and function at the NMJ.
Materials and methods
Fly stocks
Flies were cultured on standard medium at 25°C. The following fly stocks 
were used: UAS-GFP-Nmo (gift from R. Fiehler and T. Wolff, Washington 
University, St. Louis, MO; Fiehler and Wolff, 2008), UAS-Mito-GFP (Cox 
and Spradling, 2003), UAS-mCD8-GFP (Lee and Luo, 1999), UAS-Tkv
Q199D 
(UAS-Tkv-act in this study; Hoodless et al., 1996), Df(3L)pbl-X1, Df(3L)pbl-NR, 
Df(3L)Exel6279 (Parks et al., 2004), Mad
K00237 (Mad
237 in this study; Bach 
et al., 2003), Mad
6 (Sekelsky et al., 1995), nmo
P (Choi and Benzer, 
1994), nmo
DB24 (Zeng and Verheyen, 2004), and hiw
EMS (Wan et al., 
2000). Wild type refers to w
1 or w
1118 (Bloomington Stock Center). The 
neuronal Gal4 driver BG380 (Budnik et al., 1996) or OK6 and the muscle-
specific Gal4 driver G14 (Aberle et al., 2002) were used.
hiw suppressor screen
To identify dominant suppressors of synaptic overgrowth in hiw mutants, we 
crossed  hiw
EMS  recombined  with  Shaker-mCD8-GFP  (Wan  et  al.,  2000;   
McCabe et al., 2004) females to chromosomal deficiency lines available on 
the left arm of the third chromosome from the Bloomington Deficiency kit 
(Bloomington Stock Center). We examined the hemizygous male hiw
EMS/
Y;;Df/+ offsprings for reductions in NMJ boutons. We identified Df(3L)pbl-X1 
as a dominant suppressor and subsequently found that the smaller deficiency’s 
Df(3L)pbl-NR and Df(3L)Exel6279 also suppressed hiw. Among candidate 
genes uncovered by these deficiencies was nmo. We found that nmo mutants 
also suppressed hiw overgrowth; thus, we initiated our analysis of nmo.
Transgenic flies
For UAS-Myc-Mad, the full-length ORF of the Mad gene (FBgn0011648) 
was subcloned into a pUAST vector (Brand and Perrimon, 1993) con-
taining six N-terminal Myc repeats (pUAST-Myc). For UAS-Myc-Mad
S25A, 
serine 25 was mutated to alanine by PCR using the primers 5-TCACAGC-
GCCGGCGGTGAAGAAGCTGCTGGGCTGG-3 and 5-CCGGCGCTG-
TGAAGGAGAATAGCGAGCCCAGTGTG-3, respectively, in combination 
with the XbaI-linked primer 5-GGGGATCCTAATGGACACCGACGAT-3 
and  the  BamHI-linked  primer  5-GCTCTAGAGCTTAGGATACCGAAC-
TAATTGCAT-3. After an overlapping PCR, the assembled product was 
subcloned into pUAST-Myc. For UAS-GFP-Nmo
K69M, site-directed muta-
genesis was performed on UAS-GFP-Nmo wild type using the primers   
indicates current (8 nA for EJCs and 2 nA for mEJCs). (G) Graph of mEJC amplitude, EJC amplitude, quantal content (QC), and frequency of mEJCs for the 
following genotypes: BG380/+ (control), BG380/+;Mad237/+ (Mad/+), BG380/+;Mad
237/237 (Mad), BG380/+;Mad
237/237;UAS-Myc-Mad (Mad
WT 
rescue),  BG380/+;Mad
237/237;UAS-Myc-Mad
S25A/+  (Mad
S25A  rescue),  BG380/+;nmo
DB24/Df(3L)Exel6279  (nmo),  BG380/+;nmo
DB24,  UAS-GFP-Nmo/
Df(3L)Exel6279 (Nmo rescue), BG380/+;UAS-GFP-Nmo (Nmo OE; n ≥ 10 for all genotypes; mean ± SEM; *, P < 0.05; **, P < 0.01; ***, P < 0.001). 
(H and I) Dorsal motor neurons in the ventral nerve cords of larvae expressing UAS-Myc-Mad alone or UAS-Myc-Mad together with UAS-GFP-Nmo are 
shown. Note the change in the distribution of Myc signal. (J) An NMJ at muscle 4 for the same genotype as in I is shown; Myc-Mad accumulates normally 
at the NMJ. OE, overexpression. Bars, 10 µm.
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it to the Fas2 signal at the same NMJ using MetaMorph software.
For Myc quantification at the NMJ, the integrated fluorescence sig-
nal per synaptic area was measured using the HRP signal to delineate syn-
aptic boutons. To assess the fluorescence signals associated with p-Mad, 
-gal, and Myc in the nuclei of motor neurons, a standard area of 25 µm
2 
per motor neuron nucleus was used for larval segments A5, A6, and A7. 
Signals were quantified with MetaMorph software.
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Statistical analysis
Data are presented as mean values ± SEM (n = number of NMJs unless 
otherwise indicated), and Student’s t tests were used to calculate statistical 
significance (*, P < 0.05; **, P < 0.01; and ***, P < 0.001).
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